Medical Doctor Program year 2019 Source: CMS Open Payments, 2026 publication

James Gruft

Pain Medicine Oakbrook Terrace, IL Medical Doctor

NPI 1417173865 CMS profile 63808

1 Transam Plaza Dr, Suite 100, Oakbrook Terrace, IL 60181

Open in the dashboard

General payments

$15,044

1 record reported · program year 2019

Research payments

$0

Paid to them · None reported · program year 2019

Ownership & investment interest

$0

None reported

Through program year 2019, James Gruft of Oakbrook Terrace, IL is reported in the CMS Open Payments database as having received $15,044 across 1 general payment and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

1 row
Year Kind Relative to this record's peak year Amount Records
2019 General $15,044 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Gruft
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to James Gruft were reported at $0. Among 757 Pain Medicine profiles paid that year, the median was $470 and the middle half received between $146 and $1,462.

Show as a table
Year James Gruft Pain Medicine median Middle half National median
2019 $15,044 $506 $144–$1,566 $163
2020 $0 $315 $96–$934 $114
2021 $0 $452 $134–$1,237 $132
2022 $0 $475 $124–$1,407 $149
2023 $0 $480 $136–$1,384 $160
2024 $0 $521 $164–$1,511 $164
2025 $0 $470 $146–$1,462 $169

Breakdown

Who paid General payments · program year 2019
  1. Allergan Inc. $15,044 1 payment

Every payment, record by record

What the payments were for General payments · program year 2019
  1. Gift $15,044 1 payment
Products named General payments · program year 2019
  1. BOTOX $15,044 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 15 drugs

Part D claims

513

Median for Physical Medicine and Rehabilitation: 276

Drug cost

$25,695

Median for Physical Medicine and Rehabilitation: $5,921

Branded share of claims

31.8%

Median for Physical Medicine and Rehabilitation: 11.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycontin Oxycodone Hcl Brand 12 $13,673
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 63 $2,270
Gabapentin Generic 84 $2,109
Oxycodone Hcl Generic 64 $1,563
Hydromorphone Hcl Generic 55 $1,453
Morphine Sulfate Er Morphine Sulfate Brand 34 $992
Morphine Sulfate Generic 20 $755
Progesterone Progesterone, Micronized Brand 30 $597
Cyclobenzaprine Hcl Generic 44 $547
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 12 $412

The 10 drugs with the highest cost, of 15 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,591 Part D prescribers listed as Physical Medicine and Rehabilitation; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 19 billing codes

Paid by Medicare

$262,966

Medicare's payments for the services billed

Medicare patients

235

Average age 66

Services billed

5,879

158 women, 77 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 63%
Depression 40%
Ischemic heart disease 24%
Diabetes 22%
Chronic kidney disease 20%
COPD 18%
Osteoporosis 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2019

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record